SULFAMETHOXAZOLE Drug Patent Profile
✉ Email this page to a colleague
When do Sulfamethoxazole patents expire, and what generic alternatives are available?
Sulfamethoxazole is a drug marketed by Ascot, Barr, Heather, Rising, Watson Labs, Abraxis Pharm, Bedford, Hikma, Hospira, Mylan Labs Ltd, Somerset, Teva Pharms Usa, Ani Pharms, Aurobindo Pharma, Chartwell Molecular, Lupin Ltd, Novitium Pharma, Prasco, Teva, Amneal Pharms Ny, Chartwell Molecules, Fosun Pharma, Glenmark Pharms Ltd, Interpharm, Martec Usa Llc, Mutual Pharm, Pliva, Roxane, Sun Pharm Industries, Usl Pharma, Vista Pharms, Able, and Heritage Pharma Avet. and is included in fifty-three NDAs.
The generic ingredient in SULFAMETHOXAZOLE is phenazopyridine hydrochloride; sulfamethoxazole; trimethoprim. There are eight drug master file entries for this compound. Additional details are available on the phenazopyridine hydrochloride; sulfamethoxazole; trimethoprim profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SULFAMETHOXAZOLE?
- What are the global sales for SULFAMETHOXAZOLE?
- What is Average Wholesale Price for SULFAMETHOXAZOLE?
Summary for SULFAMETHOXAZOLE
US Patents: | 0 |
Applicants: | 33 |
NDAs: | 53 |
Raw Ingredient (Bulk) Api Vendors: | 161 |
Clinical Trials: | 158 |
Patent Applications: | 4,275 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for SULFAMETHOXAZOLE |
DailyMed Link: | SULFAMETHOXAZOLE at DailyMed |
![SULFAMETHOXAZOLE drug patent expirations Drug patent expirations by year for SULFAMETHOXAZOLE](/p/graph/s/t/SULFAMETHOXAZOLE-patent-expirations.png)
![Drug Prices for SULFAMETHOXAZOLE](/p/graph/drug-price/SULFAMETHOXAZOLE.png)
Recent Clinical Trials for SULFAMETHOXAZOLE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Johns Hopkins University | Early Phase 1 |
Walter Reed National Military Medical Center | Phase 2 |
The Cleveland Clinic | Phase 4 |
Medical Subject Heading (MeSH) Categories for SULFAMETHOXAZOLE
Anatomical Therapeutic Chemical (ATC) Classes for SULFAMETHOXAZOLE
US Patents and Regulatory Information for SULFAMETHOXAZOLE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mutual Pharm | SULFAMETHOXAZOLE AND TRIMETHOPRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 070006-001 | Nov 14, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Fosun Pharma | SULFAMETHOXAZOLE AND TRIMETHOPRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 018598-003 | May 19, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Usl Pharma | SULFAMETHOXAZOLE AND TRIMETHOPRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 070203-001 | Nov 8, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |